Our data demonstrate that setmelanotide reactivates PVN MC4R signaling, suppresses appetite, and reverses metabolic pathology in HO, providing mechanistic insight and highlighting the urgent need for innovative therapies for CNS-related obesity. The gene discussed is MC4R; the disease is Obesity.